Cephalon up 28% on Valeant bid
Wednesday, March 30, 2011 - 14:00
in Mathematics & Economics
Shares in pharmaceutical company Cephalon soared 28 per cent Wednesday after rival Mississauga-based Valeant Pharmaceuticals International made a $73 per share takeover offer.